Results 81 to 90 of about 18,269 (215)

Systematic review of physical and dosimetric criteria for managing CIEDs in radiotherapy: A medical physicist's perspective

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 8, August 2026.
Abstract Aim Current radiotherapy (RT) guidelines for Cardiac Implantable Electronic Devices (CIEDs) are largely based on clinical management strategies and retrospective reports. This systematic review adopts a medical physics perspective to provide a critical, quantitative analysis of the technical evidence required for developing robust safety ...
Tiziana Malatesta   +15 more
wiley   +1 more source

A preference‐integrated optimization system for medical physics shift scheduling

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 8, August 2026.
Abstract Background Clinical shift scheduling for medical physicists is challenging given multidisciplinary roles and competing clinical, research, and service demands. Manual workflows often lack the flexibility and transparency needed for this complex field.
Benjamin S. Rosen   +22 more
wiley   +1 more source

Efficacy and safety of stereotactic body radiotherapy for hepatocellular carcinoma with tumor thrombus in right atrium: a two-center retrospective review

open access: yesRadiation Oncology
Background We sought to evaluate the efficacy and toxicity of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma with tumor thrombus in right atrium (RATT). Methods HCC patients with RATT treated with SBRT at two institutions between June
Yongjie Shui   +14 more
doaj   +1 more source

Radiation safety management for stereotactic body radiation therapy incidentally concurrent with Pluvicto® (Lu‐177) therapy ‐ a case report

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 8, August 2026.
Abstract A patient with castration‐resistant prostate cancer (CRPC) was referred to our clinic seeking palliative management of a painful metastasis in the left pelvis. At the time of referral, the patient was receiving [177Lu]Lu‐PSMA 617 (Pluvicto®) therapy at an outside institution, with the next scheduled administration approaching within days.
Dongxu Wang   +6 more
wiley   +1 more source

A dosimetric study of photon energy and flattening filter mode combinations in Stereotactic Central Ablative Radiotherapy

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 8, August 2026.
Abstract Background In Stereotactic Central Ablative Radiotherapy (SCART), the volume of tumor receiving the full prescribed ablative dose decreases rapidly as the prescription dose increases, posing a critical challenge. To address this issue, this study investigates the dosimetric impact of combining various photon energies and flattening filter ...
Jianwei Sun   +5 more
wiley   +1 more source

Overcoming Radiation Resistance: Ferroptosis Induction to Sensitize Solid Tumors to Radiation Therapy

open access: yesCancer Medicine, Volume 15, Issue 8, August 2026.
ABSTRACT Radiation therapy (RT) is a mainstay of treatment for a myriad of cancers, often utilized for tumors that are unable to be resected, as well as an adjunct to surgery and chemotherapy. Unfortunately, many cancers are resistant to RT‐induced damage and subsequent cell death.
Joseph Carmicheal   +4 more
wiley   +1 more source

The Impact of the G8 Score on Survival Outcomes in Patients With Head and Neck Cancer Undergoing Concurrent Radiotherapy With Cetuximab due to Contraindications With Cisplatin

open access: yesCancer Medicine, Volume 15, Issue 8, August 2026.
ABSTRACT Purpose Patients unable to receive cisplatin due to age, comorbidities, or reduced performance status are commonly treated with concurrent radiotherapy (RT) and cetuximab. This study evaluated the prognostic significance of the Geriatric 8 (G8) score and the Charlson Comorbidity Index (CCI) in predicting survival outcomes in this population ...
Esin Kiraz   +5 more
wiley   +1 more source

Stereotactic body radiation therapy is beneficial for a subgroup of patients with urothelial cancer and solitary metastatic disease: a single institution real-world experience

open access: yesRadiation Oncology
Background Standard treatment options for patients with metastatic urothelial cancer (mUC) include systemic platinum-based chemotherapy, immunotherapy, antibody-drug-conjugates, and targeted therapy.
Fernanda Costa Svedman   +6 more
doaj   +1 more source

Consecutive Daily Versus Every Other Day Stereotactic Body Radiation Therapy Scheduling for Stage I Non-small Cell Lung Cancer

open access: yesAdvances in Radiation Oncology
Purpose: The optimal delivery schedule for stereotactic body radiation therapy (SBRT) in treating stage I non-small cell lung cancer (NSCLC) is unknown.
Yue Lin, MD   +4 more
doaj   +1 more source

Impact of Surgical Resection on 5‐Year Survival in Elderly NSCLC Patients: A SEER Database Analysis With Machine Learning‐Based Predictive Modeling in Patients Aged ≥ 60 (2000–2021)

open access: yesCancer Medicine, Volume 15, Issue 8, August 2026.
ABSTRACT Background Surgical resection is the primary curative option for elderly patients with non‐small cell lung cancer (NSCLC), but its survival benefit remains debated due to comorbidities and competing risks. This study evaluated the dynamic impact of surgery on long‐term survival and developed machine learning models for prognostic prediction ...
Bo Zhou   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy